Human pharmacokinetics of XBD173 and etifoxine distinguish their potential for pharmacodynamic effects mediated by translocator protein. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bcp.15392
PubMed Identifier: 35524344
Publication URI: http://europepmc.org/abstract/MED/35524344
Type: Journal Article/Review
Volume: 88
Parent Publication: British journal of clinical pharmacology
Issue: 9
ISSN: 0306-5251